Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 934,000 | 711,000 | 1,939,000 | 1,983,000 | 1,032,000 |
| Receivables | 436,000 | 439,000 | 268,000 | 270,000 | 243,000 |
| Inventories | 531,000 | 523,000 | 224,000 | 208,000 | 186,000 |
| Other current assets | 366,000 | 424,000 | 226,000 | 213,000 | 130,000 |
| TOTAL | $2,267,000 | $2,097,000 | $2,657,000 | $2,674,000 | $1,591,000 |
| Non-Current Assets | |||||
| PPE Net | 8,485,000 | 8,666,000 | 3,227,000 | 3,255,000 | 3,223,000 |
| Investments And Advances | 189,000 | 199,000 | 0 | 0 | 0 |
| Intangibles | 900,000 | 941,000 | 33,000 | 38,000 | 46,000 |
| Other Non-Current Assets | 316,000 | 246,000 | 5,298,000 | 5,265,000 | 187,000 |
| TOTAL | $9,890,000 | $10,052,000 | $8,558,000 | $8,558,000 | $3,456,000 |
| Total Assets | $12,157,000 | $12,149,000 | $11,215,000 | $11,232,000 | $5,047,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 71,000 | 52,000 | 8,000 | 31,000 | 37,000 |
| Accounts payable and accrued liabilities | 315,000 | 351,000 | 248,000 | 216,000 | 173,000 |
| Accrued Expenses | 365,000 | 253,000 | 382,000 | 237,000 | 205,000 |
| TOTAL | $1,010,000 | $946,000 | $820,000 | $681,000 | $628,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,208,000 | 7,079,000 | 7,077,000 | 7,075,000 | 1,973,000 |
| Other Non-Current Liabilities | 732,000 | 807,000 | 484,000 | 452,000 | 394,000 |
| TOTAL | $7,966,000 | $7,884,000 | $7,560,000 | $7,528,000 | $2,367,000 |
| Total Liabilities | $8,976,000 | $8,830,000 | $8,380,000 | $8,209,000 | $2,995,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | -552,000 | -528,000 | -916,000 | -736,000 | -632,000 |
| Other shareholders' equity | 423,000 | 411,000 | 418,000 | 420,000 | 55,000 |
| TOTAL | $3,181,000 | $3,319,000 | $2,835,000 | $3,023,000 | $2,052,000 |
| Total Liabilities And Equity | $12,157,000 | $12,149,000 | $11,215,000 | $11,232,000 | $5,047,000 |